ResMed
Price: 193.57Company and Business Model
ResMed is a healthcare company specializing in cloud-connected devices and software solutions for people with sleep apnea and chronic obstructive pulmonary disease (COPD). Its core products include continuous positive airway pressure (CPAP) devices, masks, and cloud-based software for patient management. The company operates primarily in the sleep and respiratory care segments, with major revenue sources stemming from device sales, software subscriptions, and related accessories.
Investment Profile
The investment profile of ResMed is more aligned with balanced investors, given its moderate growth potential and dividend yield. The company offers a steady revenue stream while also providing some income through dividends. However, the elevated risk factors suggest caution for those seeking aggressive growth.
Fundamental metrics (experimental)
- EPS (TTM) — earnings per share for the last 12 months, $
- 10.38 OK
- Revenue QoQ — quarter-over-quarter revenue growth
- 0.6% ≈
- EPS surprise
- 2.5% in line
- 20d volatility
- 2.1% stable
- Dividend yield
- 1.3% moderate last ex-date: 2026-05-14
Track in portfolio
Price chart
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-06-03 02:51 | Hold | Sell | Weak momentum and high risk overshadow potential upside. |
| 2026-05-24 02:49 | Sell | Hold | Weak momentum and mixed fundamentals suggest caution. |
| 2026-05-08 15:18 | — | Sell | Weak momentum and high risk overshadow potential upside. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-05-01 12:52 | Robert W. Baird | Target Lowered | 254 → 225 | 203.87 |
| 2026-04-27 10:21 | KeyBanc | Target Lowered | 302 → 290 | 219.85 |
| 2026-04-13 14:44 | Evercore ISI | Target Lowered | 300 → 255 | 228.33 |
Nothing yet